Literature DB >> 11045671

Advanced glycation endproduct-modified superoxide dismutase-1 (SOD1)-positive inclusions are common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutations and transgenic mice expressing human SOD1 with a G85R mutation.

S Kato1, S Horiuchi, J Liu, D W Cleveland, N Shibata, K Nakashima, R Nagai, A Hirano, M Takikawa, M Kato, I Nakano, E Ohama.   

Abstract

To clarify the biological significance of the neuronal Lewy body-like hyaline inclusions and astrocytic hyaline inclusions characteristically found in patients with familial amyotrophic lateral sclerosis with superoxide dismutase-1 (SOD1) gene mutations and in transgenic mice expressing human SOD1 with G85R mutation, the detailed protein composition in both types of inclusions was immunohistochemically analyzed using 45 different antibodies. Both types of inclusions had very strong immunoreactivity for SOD1. The SOD1-positive inclusions in both cell types were also immunoreactive for the insoluble advanced glycation endproducts (AGEs) such as Nepsilon-(carboxymethyl)lysine (CML), pyrraline and pentosidine: both inclusions in both conditions were ultrastructurally composed of the granule-coated fibrils that had immunoreactivities to CML and pyrraline. Both types of inclusions were negative for stress-response proteins (SRPs), 4-hydroxy-2-nonenal (HNE), acrolein, nitric oxide synthases (NOSs) and nitrotyrosine as representative markers of oxidative stress. The neurons and astrocytes of the normal individuals and non-transgenic mice showed no significant immunoreactivity for SOD1, AGEs, SRPs, HNE, acrolein, NOSs or nitrotyrosine. Our results suggest that a portion of the SOD1 composing both type of inclusions, probably toxic mutant SOD1, is modified by the AGEs, and that the formation of the AGE-modified SOD1 is one of the mechanisms responsible for the aggregation involving no significant oxidative mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045671     DOI: 10.1007/s004010000226

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  11 in total

1.  Cerebellar expression of copper chaperone for superoxide, cytosolic cu/zn-superoxide dismutase, 4-hydroxy-2-nonenal, acrolein and heat shock protein 32 in patients with menkes kinky hair disease: immunohistochemical study.

Authors:  Atsushi Yokoyama; Kousaku Ohno; Asao Hirano; Masayuki Shintaku; Masako Kato; Kazuhiko Hayashi; Shinsuke Kato
Journal:  Yonago Acta Med       Date:  2014-04-28       Impact factor: 1.641

Review 2.  Antibody-based detection of advanced glycation end-products: promises vs. limitations.

Authors:  Ryoji Nagai; Jun-Ichi Shirakawa; Rei-Ichi Ohno; Kota Hatano; Hikari Sugawa; Shoutaro Arakawa; Kenta Ichimaru; Shoh Kinoshita; Noriyuki Sakata; Mime Nagai
Journal:  Glycoconj J       Date:  2016-07-15       Impact factor: 2.916

3.  Nitration and Glycation Turn Mature NGF into a Toxic Factor for Motor Neurons: A Role for p75NTR and RAGE Signaling in ALS.

Authors:  Mi Jin Kim; Marcelo R Vargas; Benjamin A Harlan; Kelby M Killoy; Lauren E Ball; Susana Comte-Walters; Monika Gooz; Yasuhiko Yamamoto; Joseph S Beckman; Luis Barbeito; Mariana Pehar
Journal:  Antioxid Redox Signal       Date:  2017-06-26       Impact factor: 8.401

4.  Autophagy-linked FYVE protein (Alfy) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS).

Authors:  Huihui Han; Wanyi Wei; Weisong Duan; Yansu Guo; Yi Li; Jie Wang; Yue Bi; Chunyan Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-11-11       Impact factor: 2.416

Review 5.  Role of RAGE in the Pathogenesis of Neurological Disorders.

Authors:  Judyta Juranek; Konark Mukherjee; Bernard Kordas; Michał Załęcki; Agnieszka Korytko; Kamila Zglejc-Waszak; Jarosław Szuszkiewicz; Marta Banach
Journal:  Neurosci Bull       Date:  2022-06-21       Impact factor: 5.271

6.  Detergent-insoluble aggregates associated with amyotrophic lateral sclerosis in transgenic mice contain primarily full-length, unmodified superoxide dismutase-1.

Authors:  Bryan F Shaw; Herman L Lelie; Armando Durazo; Aram M Nersissian; Guillan Xu; Pik K Chan; Edith B Gralla; Ashutosh Tiwari; Lawrence J Hayward; David R Borchelt; Joan S Valentine; Julian P Whitelegge
Journal:  J Biol Chem       Date:  2008-01-11       Impact factor: 5.157

7.  Amyotrophic lateral sclerosis model derived from human embryonic stem cells overexpressing mutant superoxide dismutase 1.

Authors:  Tamaki Wada; Sravan K Goparaju; Norie Tooi; Haruhisa Inoue; Ryosuke Takahashi; Norio Nakatsuji; Kazuhiro Aiba
Journal:  Stem Cells Transl Med       Date:  2012-05-08       Impact factor: 6.940

8.  Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states.

Authors:  Mercedes Prudencio; David R Borchelt
Journal:  Mol Neurodegener       Date:  2011-11-17       Impact factor: 14.195

9.  Bim links ER stress and apoptosis in cells expressing mutant SOD1 associated with amyotrophic lateral sclerosis.

Authors:  Kai Y Soo; Julie D Atkin; Manal Farg; Adam K Walker; Malcolm K Horne; Phillip Nagley
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

10.  Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

Authors:  Bruce J Lerman; Eric P Hoffman; Margaret L Sutherland; Khaled Bouri; Daniel K Hsu; Fu-Tong Liu; Jeffrey D Rothstein; Susan M Knoblach
Journal:  Brain Behav       Date:  2012-07-23       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.